【ChiCTR2300073698】Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study
ChiCTR2300073698
结束
/
/
/
2023-07-19
/
/
pilonidal sinus
Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study
Endoscopic Pilonidal Sinus Treatment (EPSiT) For Sacrococcygeal Pilonidal Sinus Disease: A Prospective Long-Term Study
The primary outcomes were duration of healing, post-operative morbidities, persistence of discharge and recurrence at 1-7 years (for cases enrolled in 2021 from 2015 respectively). The secondary outcomes were operative time, return to work, cosmetic results and patients satisfaction. Patients were observed for wound healing and discharge on follow up in OPD at 1, 3, 6 and 24 weeks. They were further followed up every year through telephonic survey for persistence or recurrence of symptoms. Patients satisfaction was assessed according to 36- Item Short Form Survey (SF-36) questionnaire filled at admission and then at 6 weeks after the surgery
单臂
探索性研究/预试验
N/A
/
nil
/
67
/
2014-03-01
2023-03-16
/
All patients presenting to the Outpatients with pilonidal sinus with or without abscess will be included in the study;
请登录查看Only failure to give consent will be excluded;
请登录查看Shifa international hospital
/
Shifa international hospital的其他临床试验
shifa college of medicine, shifa tameer e millat university islamabad的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
